Free U.S. shipping $175+

Sermorelin — Novaryn Research
Hover to zoom
Growth Hormone ResearchSynthetic GHRH 1-29 analog

Sermorelin

$79.99
10 mg

Sermorelin corresponds to the first 29 amino acids of growth-hormone-releasing hormone — the shortest fragment of the native sequence that retains receptor activity in laboratory assays.

Because it is the minimal active form, researchers use it as a baseline GHRH receptor agonist when characterizing receptor binding, signaling, or the effect of modifications made to longer or stabilized analogs.

Research areas
GHRH receptor signalingStructure–activity researchEndocrine axis studiesPreclinical research
Form: Lyophilized (freeze-dried)
Compound class
Synthetic GHRH 1-29 analog
Research category
Growth Hormone Research
SKU
NVR-SERMORELIN-10MG
Alternate name
GRF 1-29
Appearance
White lyophilized powder
Storage
Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
10 mg$79.99$8.00/mg
1
$79.99per 10 mg$8.00/mg

For research use only — not for human or animal consumption.

Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.

Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know

More detail on Sermorelin.

Analytical values reflect per-lot documentation and appear once a batch is released.

Compound
Truncation studies established that the N-terminal 29 residues of GHRH carry the receptor-activating portion of the hormone, and sermorelin is the peptide that resulted. Its short in-vitro half-life is itself informative: comparing sermorelin with protease-resistant analogs is a standard way to quantify how much of an observed difference comes from stability rather than intrinsic receptor affinity. Laboratory applications include receptor-activation assays in pituitary-derived cells and comparative work across the GHRH analog family. Research use only.
Peptide class
Synthetic GHRH 1-29 analog
Mechanism (research context)
Sermorelin is a GHRH receptor agonist widely used as a reference peptide in somatotropic-axis research.
Why it is studied
Sermorelin is one of the foundational GHRH-analog research peptides and is commonly cited alongside CJC-1295 and Mod GRF 1-29.
Current areas of research
GHRH receptor signalingStructure–activity researchEndocrine axis studiesPreclinical research

Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.

Scientific background

The 1-29 fragment of GHRH was identified as the minimal sequence retaining full receptor activity, forming the basis for sermorelin and downstream analogs.

Sermorelin has been used in decades of GHRH-pharmacology literature as a reference compound.

Related

Related research materials

View all →
Sermorelin
10 mg · $79.99
Notify me when available